Back to Search Start Over

Supplemental Figure 2 from Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 Blockade

Authors :
James W. Young
Brian C. Betts
Katharine C. Hsu
Glenn Heller
David J. Chung
Sneh Sharma
Lillian R. Talbot
Erin T. St. Angelo
Justin A. Shyer
Shane A. Curran
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

Inhibition of JAK1/2 with ruxolitinib reduces NK cell numbers and function among treated patients with myeloproliferative neoplasm (MPN).

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....9ad6fd45382878e85b8e86bb1d93b072
Full Text :
https://doi.org/10.1158/2326-6066.22538828.v1